Translator Disclaimer
Presentation + Paper
26 February 2020 Nonclinical applications of quantitative whole-body autoradiography, and imaging mass spectrometry in drug discovery and development
Author Affiliations +
Abstract
Regulatory agencies require that drug developers characterize the absorption, pharmacokinetics, distribution, metabolism, and elimination (ADME) characteristics of new small and large molecule therapeutic entities. Quantitative whole-body autoradiography (QWBA) has become the definitive tool used for the determining tissue distribution patterns and is specifically requested by the FDA for IND submissions. However, the use of imaging mass spectrometry (IMS) to examine tissue distribution of xenobiotics has quickly gained the attention of pharmaceutical researchers because it does not require the use of radiolabeled test compounds and it can specifically identify the test article and their known metabolites with high imaging resolution. This talk will describe the state-of-the-art of both techniques and present examples of their applications in drug discovery and development.
Conference Presentation
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
E. G. Solon "Nonclinical applications of quantitative whole-body autoradiography, and imaging mass spectrometry in drug discovery and development", Proc. SPIE 11219, Visualizing and Quantifying Drug Distribution in Tissue IV, 1121903 (26 February 2020); https://doi.org/10.1117/12.2551441
PROCEEDINGS
13 PAGES + PRESENTATION

SHARE
Advertisement
Advertisement
Back to Top